Periodontitis Clinical Trial
Official title:
Does the Rehabilitation of Masticatory Function and/or Brief Dietary Advice Improve the Diet and Nutrition of Older Subjects With Terminal Dentition or Full Edentulism? A Factorial Randomized Controlled Clinical Trial
Loss of masticatory function consequent to tooth loss is associated with changes in food choices and insufficient nutrition intake. To date, studies showed no significant improvement in nutrient intake with interventions based solely on dental prostheses. Pilot studies have shown positive impacts of interventions combining implant-supported fixed dental prosthesis with brief dietary interventions. The relative contribution and the potential synergy of the components of such interventions need to be determined as it has major public health implications for the community-dwelling ageing population that continues to disproportionately suffer from tooth loss and its consequences. This study tests the effect of rehabilitation of masticatory function with fixed implant supported dentures and diet re-education on the dietary intake and nutrition in older subjects with terminal dentition (stage IV periodontitis) or full edentulism. A 2 × 2 factorial randomized controlled trial of eligible adult (≥60 years) with loss of masticatory function consequent to full arch edentulism or terminal dentition (n = 120) will be conducted to test whether the rehabilitation of masticatory function with fixed implant supported dentures, diet re-education and/or their combination improves the diet and nutrition of ageing subjects. The study has been designed to detect changes in fruit and vegetable intake at 4 months using the 24-hour dietary recall method. Changes in protein as percentage of total energy, nutritional biomarkers, metabolomics, oral and gut microbiome, quality of life and masticatory function will also be assessed.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | December 31, 2024 |
Est. primary completion date | April 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility | Inclusion Criteria: - being edentulous or having the presence of terminal dentition (defined as few remaining teeth insufficient in terms of number, position and health status to provide adequate anchorage to a tooth supported or a tooth retained denture) and looking for implant-supported fixed denture treatment - accepted treatment plan for fixed implant-supported prosthesis restoring at least 10 pairs of occluding teeth - self-reported inadequate vegetable or fruit or protein intakes (patients were included if at least one of the three criteria listed below were met) I. Patients with a total average daily intake of < 80 g of poultry, meat and aquatic product. II. Patients with an average daily intake of < 200 g of fruit. III. Patients with an average daily intake of < 300 g of vegetables. - understand written and spoken Chinese and who could respond to Chinese questionnaires - able and willing to give informed consent for participation in the study - able and willing to comply with 12-month follow-up Exclusion Criteria: - general contraindications to elective oral surgery procedures - local contraindications to implant-supported immediate-loading fixed prosthesis (e.g. limited jaw opening, insufficient bone volumes/densities) - looking for replacement of existing implant-retained overdenture with implant-supported fixed denture treatment - presence of infectious disease, acute or chronic symptoms of TMJ disorder - psychiatric disorder, dementia - any dietary restriction, currently taking nutrient supplements or inability to choose his/her diet. - uncontrolled diabetes (HbA1c=7.0%) - self-reported heavy smokers (>10 cigarette/day) |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Perio-Implant Innovation Center | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
China,
Deng K, Uy SNMR, Fok C, Fok MR, Pelekos G, Tonetti MS. Assessment of masticatory function in the differential diagnosis of Stage IV periodontitis: A pilot diagnostic accuracy study. J Periodontol. 2022 Jun;93(6):803-813. doi: 10.1002/JPER.21-0660. Epub 20 — View Citation
Ellis JS, Elfeky AF, Moynihan PJ, Seal C, Hyland RM, Thomason M. The impact of dietary advice on edentulous adults' denture satisfaction and oral health-related quality of life 6 months after intervention. Clin Oral Implants Res. 2010 Apr 1;21(4):386-91. — View Citation
Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, Thomas DR, Anthony P, Charlton KE, Maggio M, Tsai AC, Grathwohl D, Vellas B, Sieber CC; MNA-International Group. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical t — View Citation
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018 Jun;89 Suppl 1:S159-S172. doi: 10.1002/JPER.18-0006. Erratum In: J Periodontol. 2018 Dec;89(12):1475. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | changes in intake of fruit and vegetables | Three 24-hour dietary recall will be conducted through interview, twice on weekdays and once on weekend. The data on food consumption will be converted into the corresponding nutrient contents based on the China Food Composition Tables Standard Edition | from baseline to 4-month | |
Secondary | Nutrient intake | The intake of fruit and vegetables, protein% of total energy according to a modified version of food-frequency questionnaire | at baseline, 4, 8, 12 and 16 months | |
Secondary | Masticatory function | Ability to mix a two-color chewing gum with 20 masticatory cycles. The obtained bolus will be pressed to a standardized height and a color image will be acquired. Quantitative data will be obtained by digital analysis of the image using variance of hue as the outcome | at baseline, 4, 8, 12 and 16 months | |
Secondary | Peri-implant oral hygiene | Modified plaque index (mPI) measured by periodontal probing | at 4, 8, 12 and 16 months for groups with implants | |
Secondary | Peri-implant soft and hard tissue health (probing depth) | Peri-implant probing depth (PD) measured by periodontal probing | at 4, 8, 12 and 16 months for groups with implants | |
Secondary | Peri-implant soft and hard tissue health (local inflammation) | Peri-implant modified bleeding index (mBI) measured by periodontal probing | at 4, 8, 12 and 16 months for groups with implants | |
Secondary | Peri-implant radiographic bone level stability | Standardized panoramic radiographic imaging will be conducted to assess the peri-implant bone level. | 4, and 12 months after dental implant placement (in the context of standard care) | |
Secondary | OHIP-14 questionnaire | the impact of oral health on the quality of life of participants assessed with the oral health impact profile (OHIP)-14. A 5-point scale was used to calculate the score for each of 14 items. The total score of OHIP-14 is in the range of 0 to 56 with higher values indicating more frequent impacts | at baseline, 4, 8, 12 and 16 months | |
Secondary | Metabolism and systemic inflammatory biomarkers (i) | blood plasma concentration of homocysteine (gas chromatography) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Metabolism and systemic inflammatory biomarkers (ii) | Plasma hs-CRP assessed by immunoturbidometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Metabolism and systemic inflammatory biomarkers (iii) | Plasma TNF-a (ELISA) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Metabolism and systemic inflammatory biomarkers (iv) | Plasma IL-1ß (ELISA) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Metabolism and systemic inflammatory biomarkers (v) | Plasma IL-6 (ELISA) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Oxidative stress biomarkers (i) | Plasma Co Q10 with liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Oxidative stress biomarkers (ii) | Plasma uric acid (the enzymatic method) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Oxidative stress biomarkers (iii) | Plasma superoxide dismutase (the chemical colorimetric method) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma vitamin A) | concentration of plasma vitamin A assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma vitamin B2) | concentration of plasma vitamin B2 assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma vitamin B12) | concentration of plasma vitamin B12 assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma folate) | concentration of plasma folate assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma vitamin C) | concentration of plasma vitamin C assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma vitamin E) | concentration of plasma vitamin E assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(plasma a-carotene) | concentration of plasma a-carotene assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(plasma ß-carotene) | concentration of plasma a-carotene assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(plasma ß-cryptoxanthin) | concentration of plasma ß-cryptoxanthin assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(plasma lycopene) | concentration of plasma lycopene assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(plasma lutein/zeaxanthin) | concentration of plasma lutein/zeaxanthin assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(plasma a-tocopherols) | concentration of plasma a-tocopherols assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(plasma ?-tocopherols) | concentration of plasma ?-tocopherols assessed by liquid chromatography-mass spectrometry | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma total cholesterol) | concentration of plasma total cholesterol (Enzymatic Measurements) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma HDL cholesterol) | concentration of plasma HDL cholesterol (Enzymatic Measurements) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma LDL cholesterol) | concentration of plasma LDL cholesterol (Enzymatic Measurements) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma triglycerides) | concentration of plasma triglycerides (Enzymatic Measurements) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional biomarker(Plasma Lpa) | concentration of plasma Lpa (Enzymatic Measurements) | at baseline, 4, 8, 12 and 16 months | |
Secondary | Metabolomics (Metabolites) | Profiling of annotated plasma metabolites (Differential plasma metabolites with P-value< 0.05 and fold change=2 or FC=0.5) based on untargeted metabolomics using liquid chromatography coupled with mass spectrometry analyses | at baseline, 4, 8, 12 and 16 months | |
Secondary | Metabolomics (Oxylipidomics) | Profiling of annotated plasma lipid metabolites (Differential lipid metabolites with P-value< 0.05 and fold change=2 or FC=0.5) based on untargeted metabolomics using liquid chromatography coupled with mass spectrometry analyses | at baseline, 4, 8, 12 and 16 months | |
Secondary | Microbiome Analysis(saliva) | Taxonomic profiling with 16S rRNA gene sequencing in saliva samples | at baseline, 4, 8, 12 and 16 months | |
Secondary | Microbiome Analysis(plaque) | Taxonomic profiling with 16S rRNA gene sequencing in subgingival plaque samples | at baseline, 4, 8, 12 and 16 months | |
Secondary | Microbiome Analysis(stool) | Taxonomic profiling with 16S rRNA gene sequencing in stool samples | at baseline, 4, 8, 12 and 16 months | |
Secondary | Nutritional status | assessment by Mini-nutrient status form with a score of 12-14 corresponding to normal nutritional status;8-11 at risk of malnutrition;0-7 malnourished | at baseline, 4, 8, 12 and 16 months | |
Secondary | Muscle strength | muscle strength assessed by Hand grip dynamometer | at baseline, 4, 8, 12 and 16 months | |
Secondary | Cognitive function(i) | cognitive function assessed with the Mini-Mental State Examination with a total score of 30. Score 27-30: normal cognition;Score 21-26: mild cognitive impairment;Score 10-20: moderate cognitive impairment;Score <10: severe cognitive impairment | at baseline, 4, 8, 12 and 16 months | |
Secondary | Cognitive function(ii) | dementia screening with the Alzheimer's disease eight-item tool. With Score 0: no cognitive impairment, Score 1-2: cognitive impairment; Score>=3: dementia | at baseline, 4, 8, 12 and 16 months | |
Secondary | Depression symptoms | assessment with the shortened Center for Epidemiologic Studies Depression Scale. The total score is the sum of 10 items. A score equal to or above 10 is considered depressed. | at baseline, 4, 8, 12 and 16 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04712630 -
Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft
|
N/A | |
Completed |
NCT06127069 -
Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device
|
N/A | |
Completed |
NCT04964167 -
Indocyanine-green Mediated Photosensitizer VS Aloe Vera Gel: Adjunct Therapy to Scaling and Root Planing in Patients With Chronic Periodontitis
|
Phase 4 | |
Completed |
NCT05906797 -
Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis.
|
N/A | |
Recruiting |
NCT03997552 -
NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration
|
N/A | |
Completed |
NCT05530252 -
Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis
|
Phase 4 | |
Completed |
NCT04881357 -
Antiplaque/Antigingivitis Effect of Lacer Oros Integral
|
N/A | |
Recruiting |
NCT03790605 -
A Clinical Trial to Study the Effect of a Drug, Curcumin in Patients With Periodontitis
|
Phase 3 | |
Enrolling by invitation |
NCT04971174 -
Outcomes of Periodontal Regenerative Treatment
|
||
Not yet recruiting |
NCT05568290 -
Interleukin-38 Levels in Individuals With Periodontitis
|
||
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Recruiting |
NCT03997578 -
Non-incised Papillae Surgical Approach (NIPSA) and Connective Tissue Graft Plus Emdogain for Periodontal Defects
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Enrolling by invitation |
NCT04956211 -
Periodontal Treatment and Ischemic Stroke
|
N/A | |
Recruiting |
NCT05971706 -
Ozone Application in Periodontal Treatment
|
N/A | |
Recruiting |
NCT06099574 -
A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora
|
||
Completed |
NCT04402996 -
Meteorin-like Levels in Individuals With Periodontitis
|
||
Active, not recruiting |
NCT05311657 -
Oral Health and Severe COPD
|
||
Not yet recruiting |
NCT06453278 -
(DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings
|
||
Not yet recruiting |
NCT05643287 -
The Effect of Time on the Outcome of Periodontal Treatment.
|
N/A |